Improving survival for NSCLC patients in the national lung cancer audit

被引：0
|
作者：
Beckett, Paul [1 ]
Woolhouse, Ian [1 ]
Peake, Mick [1 ]
Tata, Laila [2 ]
Khakwani, Aamir [2 ]
机构：
[1] Royal Coll Physicians, Clin Effectiveness & Evaluat Unit, London, England
[2] Univ Nottingham, Div Epidemiol & Publ Hlth, Nottingham, England
来源：
EUROPEAN RESPIRATORY JOURNAL | 2015年 / 46卷
关键词：
Lung cancer / Oncology; Thoracic oncology; Epidemiology;
D O I：
10.1183/13993003.congress-2015.PA4230
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
PA4230
引用
收藏
页数：2
相关论文
共 50 条
  • [31] PREDICTORS OF TRIMODALITY THERAPY USE AND OVERALL SURVIVAL IN PATIENTS WITH STAGE III NON-SMALL CELL LUNG CANCER (NSCLC) IN THE NATIONAL CANCER DATABASE
    Fidler, Mary Jo
    Liptay, Micheal
    Bonomi, Philip
    Sher, David
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S137 - S138
  • [32] Audit of high dose palliative radiotherapy survival outcomes in patients with non-small cell lung cancer (NSCLC) in Leeds between 1999 and 2009
    Murray, P. F.
    Illsley, A. L.
    Bond, M. G.
    Bottomley, D. M.
    Franks, K. N.
    Henry, A. M.
    Snee, M. P.
    Turner, R. N.
    LUNG CANCER, 2011, 71 : S40 - S40
  • [33] National audit shows improving survival rates from bowel cancer but worrying regional variations in case management
    O'Dowd, Adrian
    BRITISH MEDICAL JOURNAL, 2009, 339
  • [34] Improving lung cancer survival; time to move on
    Heuvers, Marlies E.
    Hegmans, Joost P.
    Stricker, Bruno H.
    Aerts, Joachim G.
    BMC PULMONARY MEDICINE, 2012, 12
  • [35] Improving lung cancer survival; time to move on
    Marlies E Heuvers
    Joost P Hegmans
    Bruno H Stricker
    Joachim G Aerts
    BMC Pulmonary Medicine, 12
  • [36] Molecular testing for patients with advanced lung cancer in England: real-world evidence from the National Lung Cancer Audit
    Navani, N.
    Tweedie, J.
    Khakwani, A.
    Hubbard, R.
    Wood, N.
    Harden, S.
    Popat, S.
    Beckett, P.
    LUNG CANCER, 2020, 139 : S62 - S63
  • [37] Audit of 1 year survival for patients receiving chemotherapy for NSCLC - all comers
    Allison, J. L. E.
    Lord, H.
    LUNG CANCER, 2016, 91 : S29 - S29
  • [38] Factors affecting survival in elderly patients with non-small cell lung cancer (NSCLC)
    Athar, U.
    Gandhi, M.
    Lappin, S.
    Newman, N.
    Rajan, A.
    Gajra, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [39] Effect of Statins and Metformin on Survival in Patients With Non-small Cell Lung Cancer (NSCLC)
    Duma, Narjust
    Kang, Mohleen
    Abu-Ihweij, Khaleb
    Moaz, Choudhary
    DosSantos, Maira
    Gandhi, Arpita
    Gutierrez, Martin
    CHEST, 2015, 148 (04)
  • [40] Comorbidity and survival in advanced non-small cell lung cancer (NSCLC) veteran patients
    Chang, V. T.
    Hoover, D. R.
    Cogswell, J.
    Cholankeril, M.
    Badin, S.
    Yang, W.
    Yan, H.
    Gonzalez, M. L.
    Einhorn, J.
    Kasimis, B. S.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
12345